Nancy Chu

975 total citations
23 papers, 795 citations indexed

About

Nancy Chu is a scholar working on Molecular Biology, Pharmacology and Biochemistry. According to data from OpenAlex, Nancy Chu has authored 23 papers receiving a total of 795 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 5 papers in Pharmacology and 4 papers in Biochemistry. Recurrent topics in Nancy Chu's work include Pharmacogenetics and Drug Metabolism (5 papers), Peroxisome Proliferator-Activated Receptors (5 papers) and Eicosanoids and Hypertension Pharmacology (3 papers). Nancy Chu is often cited by papers focused on Pharmacogenetics and Drug Metabolism (5 papers), Peroxisome Proliferator-Activated Receptors (5 papers) and Eicosanoids and Hypertension Pharmacology (3 papers). Nancy Chu collaborates with scholars based in United States, Switzerland and Belarus. Nancy Chu's co-authors include Kwan Leung, Leo Gu, Andrew R. Miksztal, William A. Lee, M. D. Chaplin, Jeff Zablocki, Edward W. Swenson, Wendell H. Rooks, C. Nerenberg and Ziad Hussein and has published in prestigious journals such as Nature Medicine, Analytical Biochemistry and Journal of Medicinal Chemistry.

In The Last Decade

Nancy Chu

22 papers receiving 745 citations

Peers

Countries citing papers authored by Nancy Chu

Since Specialization

Citations

This map shows the geographic impact of Nancy Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy Chu more than expected).

Fields of papers citing papers by Nancy Chu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nancy Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy Chu. The network helps show where Nancy Chu may publish in the future.

Co-authorship network of co-authors of Nancy Chu

This figure shows the co-authorship network connecting the top 25 collaborators of Nancy Chu. A scholar is included among the top collaborators of Nancy Chu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nancy Chu. Nancy Chu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Inhibition of aldehyde dehydrogenase-2 suppresses cocaine seeking by generating THP, a cocaine use–dependent inhibitor of dopamine synthesis 2010 ·Nature Medicine ·Lina Yao, Peidong Fan, María Pía Arolfo, Zhan Jiang, M. Foster Olive, Jeff Zablocki, (unknown), Nancy Chu, (unknown), Hee‐Yong Kim, Kwan Leung, John C. Shryock, Brent Blackburn, Ivan Diamond	80
2	Potent, orally bioavailable, liver-selective stearoyl-CoA desaturase (SCD) inhibitors 2009 ·Bioorganic & Medicinal Chemistry Letters ·Dmitry O. Koltun, (unknown), Vasily A. Migulin, (unknown), (unknown), (unknown), Malcolm J. McGregor, (unknown), Nancy Chu, (unknown), Névéna Mollova, Kwan Leung, Jeffrey W. Chisholm, Jeff Zablocki	23
3	Orally bioavailable, liver-selective stearoyl-CoA desaturase (SCD) inhibitors 2009 ·Bioorganic & Medicinal Chemistry Letters ·Dmitry O. Koltun, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Andrew G. Cole, Ian Henderson, (unknown), (unknown), Nancy Chu, (unknown), Névéna Mollova, Kwan Leung, Jeffrey W. Chisholm, Jeff Zablocki	38
4	Characterization of the potency, selectivity, and pharmacokinetic profile for six adenosine A2A receptor antagonists 2007 ·Naunyn-Schmiedeberg s Archives of Pharmacology ·Ming Yang, (unknown), Sandriyana Soelaiman, Rao Kalla, Jeff Zablocki, Nancy Chu, Kwan Leung, Lina Yao, Ivan Diamond, Luiz Belardinelli, John C. Shryock	70
5	Studies to Investigate the Pharmacokinetic Interactions Between Ranolazine and Ketoconazole, Diltiazem, or Simvastatin During Combined Administration in Healthy Subjects 2005 ·The Journal of Clinical Pharmacology ·Markus Jerling, (unknown), Kwan Leung, Nancy Chu, Hisham Abdallah, Ziad Hussein	75
6	ICT AND CAUSALITY IN THE NEW ZEALAND ECONOMY 2005 ·(unknown), Nancy Chu, (unknown)	13
7	Novel inhibitors of fatty acid oxidation as potential metabolic modulators 2004 ·Bioorganic & Medicinal Chemistry Letters ·Elfatih Elzein, Kevin D. Shenk, Prabha N. Ibrahim, (unknown), S.S. Kerwar, Stephanie Meyer, (unknown), Dewan Zeng, Nancy Chu, (unknown), Shirley M.E. Wong, Kwan Leung, Jeff Zablocki	6
8	The discovery of a selective, high affinity A2B adenosine receptor antagonist for the potential treatment of asthma 2004 ·Bioorganic & Medicinal Chemistry Letters ·Jeff Zablocki, Rao Kalla, Thao Perry, Venkata P. Palle, (unknown), Dengming Xiao, Anthony D. Piscopio, (unknown), (unknown), (unknown), Nancy Chu, Kwan Leung, Dewan Zeng	56
9	CVT-4325: a potent fatty acid oxidation inhibitor with favorable oral bioavailability 2004 ·Bioorganic & Medicinal Chemistry Letters ·Elfatih Elzein, Prabha N. Ibrahim, Dmitry O. Koltun, (unknown), Kevin D. Shenk, (unknown), (unknown), Xiaofen Li, Reina Natero, Yuan Li, Marie L. Nguyen, S.S. Kerwar, Nancy Chu, (unknown), (unknown), (unknown), (unknown), Dewan Zeng, Kwan Leung, Jeff Zablocki	25
10	New fatty acid oxidation inhibitors with increased potency lacking adverse metabolic and electrophysiological properties 2003 ·Bioorganic & Medicinal Chemistry Letters ·Dmitry O. Koltun, (unknown), Kevin D. Shenk, Elfatih Elzein, Yuan Li, Marie L. Nguyen, S.S. Kerwar, Dewan Zeng, Nancy Chu, (unknown), (unknown), (unknown), (unknown), (unknown), Heather Fraser, Jeffery A. Zablocki	22
11	Affinity and intrinsic efficacy (IE) of 5′-carbamoyl adenosine analogues for the A1 adenosine receptor—efforts towards the discovery of a chronic ventricular rate control agent for the treatment of atrial fibrillation (AF) 2003 ·Bioorganic & Medicinal Chemistry Letters ·Venkata P. Palle, (unknown), Prabha N. Ibrahim, (unknown), Zhihe Li, Zhenhai Gao, Mark Ozeck, Yuzhi Wu, Dewan Zeng, Lin Wu, Kwan Leung, Nancy Chu, Jeff Zablocki	9
12	Chemical and Enzymatic Degradation of Ganciclovir Prodrugs: Enhanced Stability of the Diadamantoate Prodrug Under Acid Conditions 1991 ·Pharmaceutical Research ·Michael F. Powell, (unknown), Nancy Chu, (unknown), (unknown), (unknown), R. W. Bergstrom	8
13	Bioavailability Improvement of Mycophenolic Acid Through Amino Ester Derivatization 1990 ·Pharmaceutical Research ·William A. Lee, Leo Gu, Andrew R. Miksztal, Nancy Chu, Kwan Leung, (unknown)	202
14	Enhancement of Solubility, Dissolution Rate, and Oral Bioavailability of Rs-82856 by Complex Formation with Cyclodextrins 1989 ·Drug Development and Industrial Pharmacy ·(unknown), Stephanie A. Sweetana, Nancy Chu, (unknown), Ian J. Massey	5
15	Inhibitors of cyclic AMP phosphodiesterase. 4. Synthesis and evaluation of potential prodrugs of lixazinone (N-cyclohexyl-N-methyl-4-[(1,2,3,5-tetrahydro-2-oxoimidazo[2,1-b]quinazolin-7-yl)oxy]butyramide, RS-82856) 1988 ·Journal of Medicinal Chemistry ·Michael C. Venuti, Robert Alvarez, John Bruno, Arthur M. Strosberg, (unknown), (unknown), Ian J. Massey, Nancy Chu, John H. Fried	21
16	Disposition of nafarelin acetate, a potent agonist of luteinizing hormone-releasing hormone, in rats and rhesus monkeys. 1985 ·Drug Metabolism and Disposition ·Nancy Chu, Rebecca L. Chan, (unknown), M. D. Chaplin	16
17	Radioimmunoassay of nafarelin ([6-(3-(2-naphthyl)-d-alanine)]-luteinizing hormone-releasing hormone) in plasma or serum 1984 ·Analytical Biochemistry ·(unknown), (unknown), Nancy Chu, M. D. Chaplin, Stanley Kushinsky	12
18	In vitro studies on the binding of cloprednol to human plasma proteins 1982 ·Journal of Steroid Biochemistry ·R. V. Tomlinson, Richard Runkel, M. D. Chaplin, Larry E. Bowen, (unknown), Nancy Chu	7
19	Isolation and identification of an oxidatively defluorinated metabolite of flunisolide in man. 1981 ·Drug Metabolism and Disposition ·L Tökès, (unknown), Michael L. Maddox, M. D. Chaplin, Nancy Chu	0
20	Mechanism for the oxidative defluorination of flunisolide. 1981 ·Journal of Pharmacology and Experimental Therapeutics ·Philip Teitelbaum, Nancy Chu, (unknown), L Tökès, (unknown), (unknown), M. D. Chaplin	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact